Table 2.
Performance | Con | OA+B |
---|---|---|
BW, g | ||
d 1 | 40.21 ± 0.30 | 40.09 ± 0.18 |
d 42 | 2750.67 ± 94.41 | 2688.64 ± 113.15 |
ADG, g | ||
d 1–21 | 44.09 ± 0.86 | 42.20 ± 1.32 |
d 1–42 | 64.53 ± 2.25 | 63.06 ± 2.69 |
ADFI, g | ||
d 1–21 | 59.46 ± 2.73 | 47.56 ± 1.83* |
d 1–42 | 134.01 ± 6.32 | 122.89 ± 5.20 |
FCR | ||
d 1–21 | 1.35 ± 0.06 | 1.13 ± 0.05* |
d 1–42 | 2.07 ± 0.03 | 1.95 ± 0.03* |
indicates significant difference (P ≤ 0.05) between 2 groups at each growth period. Dietary treatments were as follows: Con, basal diet; OA+B, basal diet + 500 ppm microencapsulated organic acids and botanicals.